Next Article in Journal
Application and Optimization of relE as a Negative Selection Marker for Making Definitive Genetic Constructs in Uropathogenic Escherichia coli
Previous Article in Journal
Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections
Previous Article in Special Issue
Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
Article Menu

Export Article

Open AccessReview
Pathogens 2016, 5(1), 8;

Viral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait?

Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive, Birmingham B15 2TT, UK
Present address; Virginia Commonwealth University, School of Dentistry, W. Baxter Perkinson Jr. Building, 521 North 11th Street, P.O. Box 980566, Richmond, VA 23298-0566, USA
Author to whom correspondence should be addressed.
Academic Editor: Lawrence S. Young
Received: 23 November 2015 / Revised: 14 January 2016 / Accepted: 15 January 2016 / Published: 18 January 2016
(This article belongs to the Special Issue Infection and Cancer)
Full-Text   |   PDF [730 KB, uploaded 18 January 2016]   |  


Many of the human viruses with oncogenic capabilities, either in their natural host or in experimental systems (hepatitis B and C, human T cell leukaemia virus type 1, Kaposi sarcoma herpesvirus, human immunodeficiency virus, high-risk human papillomaviruses and adenovirus type 9), encode in their limited genome the ability to target cellular proteins containing PSD95/ DLG/ZO-1 (PDZ) interaction modules. In many cases (but not always), the viruses have evolved to bind the PDZ domains using the same short linear peptide motifs found in host protein-PDZ interactions, and in some cases regulate the interactions in a similar fashion by phosphorylation. What is striking is that the diverse viruses target a common subset of PDZ proteins that are intimately involved in controlling cell polarity and the structure and function of intercellular junctions, including tight junctions. Cell polarity is fundamental to the control of cell proliferation and cell survival and disruption of polarity and the signal transduction pathways involved is a key event in tumourigenesis. This review focuses on the oncogenic viruses and the role of targeting PDZ proteins in the virus life cycle and the contribution of virus-PDZ protein interactions to virus-mediated oncogenesis. We highlight how many of the viral associations with PDZ proteins lead to deregulation of PI3K/AKT signalling, benefitting virus replication but as a consequence also contributing to oncogenesis. View Full-Text
Keywords: oncogenic viruses; PDZ proteins; cell polarity; PI3K/AKT signalling; HPV E6; adenovirus E4ORF1; DLG1; SCRIB; tight junctions oncogenic viruses; PDZ proteins; cell polarity; PI3K/AKT signalling; HPV E6; adenovirus E4ORF1; DLG1; SCRIB; tight junctions

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

James, C.D.; Roberts, S. Viral Interactions with PDZ Domain-Containing Proteins—An Oncogenic Trait? Pathogens 2016, 5, 8.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top